You can be aware of the latest ESBL E.Coli news on a daily basis. Every day there are up to 10-15 new ESBL stories. We sort them, weed out the duplicates and then create two things. A free daily newsletter, and our Twitter feed. Save yourself hours and be informed in ways that will practically help you, whether you are a patient or a health care worker. See the latest news below and scroll down for a guide to where we get it from and why you can trust it, also make sure to Buy std testing kits in los angeles, it has proven to be one of the most reliable clinics to trust with your sexual health.
- Ceftazidime-Avibactam Antimicrobial Activity and Spectrum When Tested against Gram-negative Organisms from Pediatric Patients: Results from the INFORM Surveillance Program (United States, 2011-2015).
- Deep Interviews with Game Changers of Infection Prevention (Part 1) - www.IC.tips
- Healthcare associated bloodstream infections in Polish hospitals: prevalence, epidemiology and microbiology—summary data from the ECDC Point Prevalence Survey of Healthcare Associated Infections 2012–2015 | SpringerLink
- Quantifying Hospital-Acquired Carriage of Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae Among Patients in Dutch Hospitals | Infection Control & Hospital Epidemiology | Cambridge Core
- The prevention paradox: E. coli versus Klebsiella | Reflections on Infection Prevention and Control
- Digestive tract colonization by multidrug-resistant Enterobacteriaceae in travellers: An update. - PubMed - NCBI
- Risk factors associated with the A2C resistance pattern among E. coli isolates from broiler flocks in Canada. - PubMed - NCBI
- Infections Caused by Antimicrobial Drug-Resistant Saprophytic Gram-Negative Bacteria in the Environment. - PubMed - NCBI
- Molecular relatedness of ESBL/AmpC-producing Escherichia coli from humans, animals, food and the environment: a pooled analysis. - PubMed - NCBI
- Antimicrobial-resistant Faecal Organisms in Algae Products Marketed as Health Supplements. - PubMed - NCBI
- The Role of Cefepime in the Treatment of Extended-Spectrum Beta-Lactamase Infections. - PubMed - NCBI
- Risk of Transmission of Antimicrobial Resistant Escherichia coli from Commercial Broiler and Free-Range Retail Chicken in India. - PubMed - NCBI
- Predicament in Detection and Reporting of Extended Spectrum Beta Lactamase Production in Routine Antibiotic Susceptibility Testing. - PubMed - NCBI
- Virulence and extended-spectrum β-lactamase encoding genes in Escherichia coli recovered from chicken meat intended for hospitalized human consumpt... - PubMed - NCBI
- Antimicrobial Resistance in Escherichia coli Isolated from Wild Animals in Poland. - PubMed - NCBI
ESBL E.Coli News – Medical Journals
We monitor medical journals for the latest research on issues surrounding ESBL. We pay particular attention to items about transmission, treatment, key ESBL drugs and infection control. With over 500 relevant journal articles being released every year, our service can help you see the latest research headlines at a glance.
ESBL News – Twitter
We discover cutting edge analysis via the Twitter accounts of leading infection control specialists, medical journalists and national and international agencies. These unique voices are at the heart of the science surrounding ESBL and the discussions about key trends and best practice.
ESBL – Mainstream media
Newspapers all over the world carry ESBL E.Coli related news. We monitor this using news alert software and add key stories to our news feed as well as removing the many duplicates of the same story that sometimes appear. The media shape popular perceptions of the extent and impact of ESBL. Our ESBL news service helps you discover, in 2 minutes a day, the important stories that you might want to explore further.
The newsletter and Twitter feed we offer are unique. We believe they will be helpful to infection control specialists, general nursing staff, patient advocates, medical equipment manufacturers and those working on ESBL E.Coli related drug projects. They are both free. Sponsors for the newsletter are welcome – you can find more information by emailing dave(at)tahilla.com